|
Market Closed -
Nasdaq
16:00:00 2026-11-03 EST
|
5-day change | 1st Jan Change | ||
| 3.500 USD | +14.75% |
|
+11.11% | -78.12% |
| 10-29 | LENZ Therapeutics, Inc., Q3 2026 Earnings Call, Oct 29, 2026 | |
| 10-28 | LENZ Therapeutics, Inc. Decreases Headcount By Approximately 75% To Approximately 40 Full-Time Employees | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| LENZ | Delayed | |
CBOE
| LENZ | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 3.96 | 5.96 | 10.06 |
| Spread/Res. | -11.62% | -41.28% | -65.21% |
| Spread/Supp. | +14.75% | +14.75% | +14.75% |
| Support | 3.05 | 3.05 | 3.05 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- LENZ Stock
- Charts LENZ Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
